Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiguo Hu

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Journal of Chemical Information and Modeling|March 17, 2017
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship AnalysisShenzhen Huang, Chunli Song, Xiang Wang, et al.
Blood|December 10, 2013
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistanceZe Tian, Padraig D'Arcy, Xin Wang, et al.
American Journal of Cancer Research|July 11, 2022
Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemiaYang Dai, Jingcao Huang, Pu Kuang, et al.
Cell Death and Differentiation|January 16, 2019
The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expressionYu Xiong, Linli Li, Liting Zhang, et al.
Cell Reports|March 31, 2025
Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven diseaseLingyun Zhou, Chang-Hai Liu, Duoduo Lv, et al.
Oncotarget|November 1, 2019
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myelomaQiang Qiu, Mengyuan Li, Linyu Yang, et al.
Bioengineering & Translational Medicine|February 3, 2022
High-dose vitamin D metabolite delivery inhibits breast cancer metastasisJiaye Liu, Junyi Shen, Chunyang Mu, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 17, 2023
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN functionLi Zheng, Cong Pan, Wanli Tian, et al.
Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Blood|September 18, 2012
Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cellsZe Tian, Jian-jun Zhao, Yu-Tzu Tai, et al.
Journal of Chemical Information and Modeling|March 17, 2017
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship AnalysisShenzhen Huang, Chunli Song, Xiang Wang, et al.
Blood|December 10, 2013
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistanceZe Tian, Padraig D'Arcy, Xin Wang, et al.
American Journal of Cancer Research|July 11, 2022
Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemiaYang Dai, Jingcao Huang, Pu Kuang, et al.
Cell Death and Differentiation|January 16, 2019
The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expressionYu Xiong, Linli Li, Liting Zhang, et al.
Cell Reports|March 31, 2025
Halting hepatocellular carcinoma: Identifying intercellular crosstalk in HBV-driven diseaseLingyun Zhou, Chang-Hai Liu, Duoduo Lv, et al.
Oncotarget|November 1, 2019
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myelomaQiang Qiu, Mengyuan Li, Linyu Yang, et al.
Bioengineering & Translational Medicine|February 3, 2022
High-dose vitamin D metabolite delivery inhibits breast cancer metastasisJiaye Liu, Junyi Shen, Chunyang Mu, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 17, 2023
Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN functionLi Zheng, Cong Pan, Wanli Tian, et al.
Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.
Pageof 6